Skye Bioscience, Inc. (SKYE) Operating income 2016–2025
Skye Bioscience, Inc. (SKYE) annual operating income history from SEC filings — each fiscal year as reported.
-$58.2MFY2025 · since FY2016: -$4.5M → -$58.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$58.2M | -92.6% |
| FY2024 | -$30.2M | +13.1% |
| FY2023 | -$34.7M | -89.7% |
| FY2022 | -$18.3M | -133.3% |
| FY2021 | -$7.8M | -24.8% |
| FY2020 | -$6.3M | +5.2% |
| FY2019 | -$6.6M | -41.3% |
| FY2018 | -$4.7M | -21.6% |
| FY2017 | -$3.9M | +13.7% |
| FY2016 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice